RISK ANALYSIS OF THE DEFICIENCIES FOUND BY THE GMP INSPECTIONS
A review of GMP-inspections results and the main found deficiencies was carried out. It was established that in the field of inspection of pharmaceutical companies the unresolved problems with the interpretation of the revealed deficiencies are still, i.e. with the objective (a unified, standardized...
Saved in:
| Main Authors: | Yu. V. Podpruznikov, V. N. Shestakov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2019-01-01
|
| Series: | Разработка и регистрация лекарственных средств |
| Subjects: | |
| Online Access: | https://www.pharmjournal.ru/jour/article/view/244 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Responsibilities of the Marketing Authorisation Holders in Respect of GMP Compliance (Review)
by: A. P. Meshkovskiy, et al.
Published: (2020-11-01) -
RADIATION SAFETY PROVISIONS DURING THE USE OF RADIATION INSPECTION INSTALLATIONS AND RADIATION SCANNERS FOR THE PEOPLE PERSONAL INSPECTION
by: A. N. Barkovsky, et al.
Published: (2015-10-01) -
Preparation for the Inspection of the Pharmacovigilance System
by: B. K. Romanov
Published: (2021-10-01) -
Rate Setting for Labour Costs Related to Pharmacovigilance System Inspections
by: M. Abdrakhmanov, et al.
Published: (2022-04-01) -
Conducting Pharmaceutical Inspections in the Russian Federation to Ensure Compliance with the EAEU GCP Requirements Is an Accepted Necessity
by: A. A. Trapkova
Published: (2023-06-01)